Dimension Vista LOCI BNP Assay*

Proven BNP performance combined with ultra-integration for accurate heart failure diagnosis.


Many heart failure (HF) patients present with non-specific symptoms that can be associated with other conditions such as pulmonary disease, asthma, and even allergies. This makes differential diagnosis difficult when based on a patient’s clinical picture alone. Since studies prove that an assessment of a patient’s BNP level aids in the diagnosis of HF, having a rapid, accurate solution for BNP testing can improve decision time and get patients on the right course of therapy faster.
 

Features

  • Results available in as little as 12 minutes
  • Exceptional precision with total CVs of 1.1 – 4.3% across the assay range
  • Utilizes the same antibodies as those used in multiple studies to establish the clinical utility of BNP testing
  • Employs the unique LOCI technology for results in a flash
  • Perform BNP testing alongside more than 100 other assays simultaneously

 

Advantages

  • Improve decision time for more rapid initiation of treatment
  • Precision leads to accuracy, which leads to confidence in results
  • Proven BNP performance for trusted diagnosis
  • Enhance productivity and streamline cardiac patient care

Share this page:

*The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.